Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA methyltransferase activity and survival

Lignende værker

• O(6)-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
  af: Spiegl-Kreinecker, Sabine, et al.
  Udgivet: (2010)
• Activity of irinotecan and temozolomide in the presence of O(6)-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models
  af: Cai, W, et al.
  Udgivet: (2010)
• Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
  af: McAleenan, Alexandra, et al.
  Udgivet: (2021)
• Prognostic value of test(s) for O(6)‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
  af: McAleenan, Alexandra, et al.
  Udgivet: (2019)
• Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression
  af: Zhu, Zhongling, et al.
  Udgivet: (2016)